Percutaneous Transluminal Angioplasty Balloons Catheter Market

Percutaneous Transluminal Angioplasty Balloons Catheter Market Size and Trends

Percutaneous transluminal angioplasty balloons catheter market is estimated to be valued at USD 1.82 Bn in 2024 and is expected to reach USD 3.35 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.

Percutaneous Transluminal Angioplasty Balloons Catheter Market Key Factors

Discover market dynamics shaping the industry: Request sample copy

Percutaneous transluminal angioplasty balloons catheter industry can witness robust growth over the forecast period due to technological advancements such as drug-coated balloons and balloons with higher flexibility. Rising prevalence of cardiovascular diseases along with growing preference for minimally invasive procedures can drive the market growth. Furthermore, increasing healthcare spending especially in emerging economies and rising geriatric population can also drive the market growth in the near future. However, high costs associated with these devices can hamper its widespread adoption.

Percutaneous Transluminal Angioplasty Balloons Catheter Market By Type

Discover high revenue pocket segments and roadmap to it: Request sample copy

Insights, By Type- Affordability and Extensive Usage Drives Standard PTA Ballons Segment

In terms of type, standard PTA ballons segment is estimated to contribute the highest market share of 45.1% in 2024, due to its affordability and extensive usage. Preferred by both physicians and patients, these balloons have a long-standing history of effective use in angioplasty procedures. Their cost-effectiveness, proven safety, and availability in various sizes makes them suitable for diverse artery anatomies, ensuring reliable outcomes for peripheral vascular and coronary conditions.

Insights, By Material Type- Polyurethane Emerges as Material of Choice Due to Superior Properties

In terms of material type, polyurethane segment is estimated to contribute the highest market share of 61.6% in 2024, owing to its superior material properties. Its thin yet durable construction allows for effective tracking through tortuous vessels without damage. Polyurethane balloons can inflate at high pressures, facilitating artery widening, and their biocompatibility minimizes inflammation risk. With smooth surface, these balloons enable minimally traumatic interventions, making polyurethane the preferred choice over nylon and other polymers in angioplasty procedures.

Insights, By Application- Peripheral Artery Disease Dominates Application Segment Due to High Prevalence

In terms of application, peripheral artery disease segment is estimated to contribute the highest market share of 69.3% in 2024, due to its high global prevalence. This condition arises from plaque accumulation in arteries supplying blood to the hips and legs, with risk factors including age, diabetes, and smoking. The demand for specialized below-the-knee artery clearing has boosted need for targeted low-profile PTA balloons and catheters, solidifying PAD as the primary application for percutaneous angioplasty.

Regional Insights

Percutaneous Transluminal Angioplasty Balloons Catheter Market Regional Insights

To learn more about this report, Request sample copy

Dominating Region- North America

North America is expected to dominate the percutaneous transluminal angioplasty balloons catheter industry, with an estimated market share of 41.3% in 2024, due to factors such as presence of well-established healthcare infrastructure, advanced medical technologies, and high healthcare expenditure. Major players in the region such as Medtronic and Boston Scientific Corporation have been introducing innovative products, thus, driving market growth.

Fastest-Growing Region- Asia Pacific

Asia Pacific region exhibits the fastest growth in percutaneous transluminal angioplasty balloons catheter industry, with an estimated market share of 19.4% in 2024. This can be attributed to increasing patient awareness, improving access to healthcare, and supportive government policies promoting local manufacturing. Leading global companies are focusing on their expansion strategies in the region to tap into high-potential market.

Percutaneous Transluminal Angioplasty Balloons Catheter Market Outlook for Key Countries

Products innovation in the U.S.

The U.S. market for percutaneous transluminal angioplasty balloons catheters is driven by top firms that are heavily investing in research and development to develop advanced solutions. This focus on innovation drives growth and enhances treatment options in the healthcare sector.

Growing geriatric population in China

China market for percutaneous transluminal angioplasty balloons catheters is experiencing rapid growth due to growing geriatric population, increased healthcare expenditure, and domestic manufacturers providing cost-effective products. This combination enhances access to vital medical interventions, catering to rising demand for effective cardiovascular treatments among the elderly.

Technological advancements in Japan

Japan percutaneous transluminal angioplasty balloons catheter market growth is driven by technologically advanced healthcare system and a universal health insurance framework. This system ensures equitable access to high-quality medical care, facilitating the adoption of innovative medical technologies and improving patient outcomes across the nation.

Widening patient pool and collaborative efforts in India

India's market for percutaneous transluminal angioplasty balloons catheters is experiencing significant growth due to widening patient pool and collaborative efforts from both the public and private sectors to improve accessibility. These initiatives aim to enhance healthcare infrastructure and ensure that advanced medical treatments are available to a broader population.

Market Concentration and Competitive Landscape

Percutaneous Transluminal Angioplasty Balloons Catheter Market Concentration By Players

Get actionable strategies to beat competition: Request sample copy

Top Strategies Followed by Percutaneous Transluminal Angioplasty Balloons Catheter Market Players

Established players in the percutaneous transluminal angioplasty balloons catheter industry focus heavily on research and development to introduce innovative products. Market leaders such as Medtronic, Boston Scientific, and Abbott Laboratories invest over 5% of their annual revenue in R&D. This allows them to continually enhance catheter design and develop smart integrated solutions. These companies also form strategic partnerships with other major medical device manufacturers.
Mid-sized players focus on delivering cost-effective products to gain a foothold in price-sensitive markets. Companies such as Biosensors International Group Ltd compete through efficient manufacturing processes. These also collaborate with local startups and hospitals to test new prototypes and conduct clinical trials at lower costs.
Small companies thrive by targeting specific niche segments left untapped by larger players. For instance, Spectranetics corporation has established itself as a leader in specialty balloon catheters used for vein ablation procedures. It has gained expertise through continuous technology adoption and by pioneering innovative materials like paclitaxel-coated balloons.

Emerging Startups in the Percutaneous Transluminal Angioplasty Balloons Catheter Market

Various startups are developing advanced technologies to disrupt the percutaneous transluminal angioplasty balloons catheter market. CorPath is designing smart balloon catheters integrated with pressure sensors and AI algorithms for real-time treatment monitoring. Other startups like HeartFlow are applying computational fluid dynamics to personalized heart disease evaluation, aiding more accurate catheter-based procedures.
Biotronik produces fully recyclable balloons and shafts from bioresorbable polymers lowering environmental impact. companies are exploring the viability of integrating biodegradable stents and drug coatings to minimize long-term complications.
New entrants often address unmet needs through niche innovations. For example, Biotronik's bioresorbable scaffolds offer solutions for treating complex lesions conventional drug-eluting stents cannot. Startups also partner with medical institutions to initiate collaborative R&D and jointly contribute to advancing technologies.

Percutaneous Transluminal Angioplasty Balloons Catheter Industry News

On August 5, 2024, Teleflex Incorporated, a medical device company, announced that the U.S. Food and Drug Administration had approved its new percutaneous transluminal coronary angioplasty perfusion balloon catheter. The Ringer perfusion balloon catheter features a rapid-exchange design compatible with 0.014” systems and includes a helical balloon that, when inflated, forms a hollow cylinder with a large central lumen, allowing continuous blood flow during extended inflations.
On May 3, 2024, the Swanson School of Engineering at the University of Pittsburgh announced that it had secured approximately US$ 1.1 million from the South Korean Ministry of Health and Welfare as part of its Healthcare Technology Research and Development Project to innovate the design of coronary balloon devices
In March 2021, Medtronic, a medical technology company, announced the launch of its Chameleon percutaneous transluminal angioplasty (PTA) balloon catheter in several countries, including Germany, Italy, Portugal, South Africa, Spain, and Turkey. This device is designed for use in both native and synthetic arteriovenous dialysis fistulae, as well as in femoral, iliac, and renal arteries.

Key Takeaways from Analyst

Percutaneous transluminal angioplasty balloons catheter market can witness steady growth over the next five years. Rising prevalence of cardiovascular diseases worldwide can drive the market growth due to expanding patient pool undergoing angioplasty procedures.
Strict regulatory approval process and quality standards mandated by FDA and other regulatory bodies add to the production costs. High price points of technologically advanced drug-coated and cutting balloons can also hamper the market growth.
North America currently dominates the market but Asia Pacific is likely to witness the fastest growth, owing to rapidly developing healthcare infrastructure and growing medical tourism industry in countries like India and China.

Market Report Scope

Percutaneous Transluminal Angioplasty Balloons Catheter Market Report Coverage

Report Coverage	Details
Base Year:	2023	Market Size in 2024:	US$ 1.82 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	9.1%	2031 Value Projection:	US$ 3.35 Bn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific Middle East: GCC Countries, Israel, Rest of Middle East Africa: South Africa, North Africa, Central Africa
Segments covered:	By Type: Standard PTA Ballons, High Pressure PTA Ballons, Others By Material Type: Polyurethane, Nylon, Others By Application: Peripheral Artery Disease and Coronary Artery Disease By End User: Hospital, Ambulatory Surgical Centers, Others
Companies covered:	Boston Scientific Corporation, Cardinal Health, BD, Medtronic, Terumo Medical Corporation, Cook Medical, Biotronik, AndraTec, Natec Medical, Shockwave Medical Inc., Abbott, Nipro Group Companies, Teleflex Incorporated, MicroPort Scientific Corporation
Growth Drivers:	Growing prevalence of cardiovascular diseases Rising demand for minimally invasive procedures
Restraints & Challenges:	Stringent regulatory approvals Increasing product recalls

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Market Dynamics

Market Driver- Rising demand for minimally invasive procedures

The shift towards minimally invasive surgical approaches, including angioplasty, is transforming medical practice. This method reduces recovery time, trauma, and complications for patients while lowering healthcare costs. Angioplasty is increasingly preferred over traditional bypass surgeries due to less scarring, reduced bleeding, and shorter hospital stays. As patient awareness grows and device manufacturers promote these benefits, there will be demand for angioplasty, driving innovation in catheter technology and improving procedural success rates across diverse vascular cases.

Market Challenge- Stringent regulatory approvals

Percutaneous transluminal angioplasty balloons catheter market faces challenges like stringent regulatory approval process for new products. Regulatory bodies like the U.S. FDA and European Medicines Agency require extensive clinical trials to demonstrate safety and efficacy, leading to delays in market entry. Any modifications to approved products may necessitate further approvals, increasing costs and timelines. The varying compliance requirements across countries complicate product development and hinder broader market penetration of innovative technologies.

Market Opportunity- Development of bioabsorbable stents

Development of bioabsorbable stents offers significant opportunities for the percutaneous transluminal angioplasty balloons catheter market. These stents dissolve over time, reducing the need for lifelong dual antiplatelet therapy and minimizing risks like late stent thrombosis. With promising clinical outcomes and ongoing R&D efforts, major companies are focused on advancing this technology, which could attract further investment and drive growth in related products, including balloon catheters.

Key Stakeholders of Market

What growth in percutaneous transluminal angioplasty balloons catheter industry mean for different stakeholders?

Percutaneous transluminal angioplasty balloons catheter market industry has multiple players with varied designations and offers multiple opportunities based on their scope of operations.

Key Medical Devices Stakeholder	Opportunities Due to Percutaneous Transluminal Angioplasty Balloons Catheter Industry Growth
Retail Pharmacies	Offering medical devices for home use, such as blood glucose monitors and digital thermometers, expanding product offerings and customer care services.
Medical Device Manufacturers	Expansion of product lines to include innovative devices such as wearables, smart implants, and AI-driven diagnostic tools.
Healthcare Providers	Opportunities to adopt and integrate cutting-edge medical devices into patient care, improving outcomes and expanding service offerings.
Biotech Firms	Collaborating on the development of combination products, such as drug-device combinations, offering new treatment options and expanding markets.
Regulatory Affairs Specialists	Growing demand for expertise in navigating the complex regulatory landscape for medical device approvals, ensuring compliance with global standards.
Supply Chain and Logistics Providers	Managing the distribution of sensitive and high-value medical devices, including ensuring compliance with medical regulations and standards.
Medical Device Consultants	Providing strategic guidance on product development, regulatory compliance, and market entry for medical device companies.
Healthcare Training Institutions	Expanding training programs to include the use of advanced medical devices, preparing healthcare professionals for the latest technological advancements.

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Market Segmentation

By Type Insights (Revenue, USD Bn, 2019 - 2031)
- Standard PTA Ballons
- High Pressure PTA Ballons
- Others
By Material Type Insights (Revenue, USD Bn, 2019 - 2031)
- Polyurethane
- Nylon
- Others
By Application Insights (Revenue, USD Bn, 2019 - 2031)
- Peripheral Artery Disease
- Coronary Artery Disease
By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital
- Ambulatory Surgical Centers
- Others
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- Boston Scientific Corporation
- Cardinal Health
- BD
- Medtronic
- Terumo Medical Corporation
- Cook Medical
- Biotronik
- AndraTec
- Natec Medical
- Shockwave Medical Inc.
- Abbott
- Nipro Group Companies
- Teleflex Incorporated
- MicroPort Scientific Corporation

About Author

Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.

Missing comfort of reading report in your local language? Find your preferred language :

Transform your Strategy with Exclusive Trending Reports :

Polymerase Chain Reaction Market

Automatic Pill Dispenser Machine Market

Medical Aesthetics Market

Structural Heart Devices Market

Hemostasis And Tissue Sealing Agents Market

Abdominal Aortic Aneurysm Repair Devices Market

Frequently Asked Questions

Percutaneous transluminal angioplasty balloons catheter market is estimated to be valued at US$ 1.82 Bn in 2024 and is expected to reach US$ 3.35 Bn by 2031

The CAGR of percutaneous transluminal angioplasty balloons catheter market is projected to be 9.1% from 2024 to 2031.

Growing prevalence of cardiovascular diseases and rising demand for minimally invasive procedures are the major factors driving the growth of percutaneous transluminal angioplasty balloons catheter market.

Stringent regulatory approvals and increasing product recalls are the major factors hampering the growth of percutaneous transluminal angioplasty balloons catheter market.

In terms of type, standard PTA ballons segment is estimated to dominate the market in 2024.

Boston Scientific Corporation, Cardinal Health, BD, Medtronic, Terumo Medical Corporation, Cook Medical, Biotronik, AndraTec, Natec Medical, Shockwave Medical Inc., Abbott, Nipro Group Companies, Teleflex Incorporated, MicroPort Scientific Corporation are the major players.

North America is expected to lead the percutaneous transluminal angioplasty balloons catheter market in 2024.